888-430-5470
  • Facebook
  • Twitter
  • Google
  • Facebook
  • Twitter
  • Google
Drug Outlook
  • Drugs & Devices
    • Actos
    • Benicar
    • Da Vinci Robots
    • Essure
    • Granuflo
    • Hip Implants
    • INFUSE® Bone Graft
    • IVC Filters
    • Physiomesh
    • Power Morcellator
    • Pradaxa
    • Risperdal
    • SGLT2 Inhibitors
    • Talcum Powder
    • Testosterone Therapy
    • Transvaginal Mesh
    • Viagra
    • Xarelto
    • Zofran
  • Manufacturers
    • AbbVie & Abbott
    • Boehringer Ingelheim
    • Eli Lilly
    • GlaxoSmithKline
    • Takeda Pharma
  • Current Lawsuits
    • Case Evaluation
  • News
  • DrugHub©
Select Page
  • Drugs & Devices
    • Actos
    • Benicar
    • Da Vinci Robots
    • Essure
    • Granuflo
    • Hip Implants
    • INFUSE® Bone Graft
    • IVC Filters
    • Physiomesh
    • Power Morcellator
    • Pradaxa
    • Risperdal
    • SGLT2 Inhibitors
    • Talcum Powder
    • Testosterone Therapy
    • Transvaginal Mesh
    • Viagra
    • Xarelto
    • Zofran
  • Manufacturers
    • AbbVie & Abbott
    • Boehringer Ingelheim
    • Eli Lilly
    • GlaxoSmithKline
    • Takeda Pharma
  • Current Lawsuits
    • Case Evaluation
  • News
  • DrugHub©

Price-Gouging for Profit: The Rise and Fall of Valeant

by Mooslet Writing Services | Jun 30, 2016 | Uncategorized

The rise and fall of Valeant Pharmaceuticals may be a teachable moment for the entire pharma industry: gouge the public at your peril. On July 31, 2015, the Canadian company seemed like a pharma dream come true. On that date, Valeant’s stock price hit an all-time high...

Delaware Increases Access to Hepatitis C Medicines

by Mooslet Writing Services | Jun 14, 2016 | Uncategorized

Delaware state health officials have agreed to change the state’s Medicaid guidelines to make it easier for patients to get Hepatitis C medicine. The move comes as a result of a demand letter sent to Delaware state officials by the Center for Health Law and Policy...

Recent Posts

  • Price-Gouging for Profit: The Rise and Fall of Valeant
  • Drug Wholesalers Settle Opioid Lawsuit
  • Lawmakers Fight To Improve Access to Generic Drugs
  • Million-Dollar Drugs: Gene Therapy No One Can Afford
  • WHO Endorses Olympics Despite Zika Virus

Recent Comments

  • Namaste927 on Lioresal
  • Mietzekatze on Maxzide
  • Jack on Zyloprim

Archives

  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • October 2015

Categories

  • Big Pharma Business
  • Big Pharma Lawsuits
  • Clinical Trials
  • Consumer Healthcare
  • FDA
  • Prescription Drugs
  • Uncategorized

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

THIS IS A PAID ATTORNEY/ADVOCATE ADVERTISEMENT. This website is a group advertisement and a fee is paid for by participating attorneys and advocates. The site is not an attorney referral service or prepaid legal services plan. The information provided by Drug Outlook is not a substitute for professional medical advice, diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of Drug Outlook. This website does not make any representation to the qualifications, expertise or credentials of participating attorneys/advocates and does not represent that quality is better than services performed by other attorneys/advocates. Any information you submit to this website may not be protected by attorney-client privilege. An automated matching system will match each request with a member attorney/advocate representing the specific geography.

If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: webmaster@drugoutlook.com

©2015 DrugOutlook.com. View our Terms of Use or Privacy Policy.